✦ LIBER ✦

Oncogene chromosome breakpoints and Alu sequences (reply)

✍ Scribed by HEISTERKAMP, NORA; GROFFEN, JOHN

Book ID: 109741471
Publisher: Nature Publishing Group
Year: 1985
Tongue: English
Weight: 129 KB
Volume: 317
Category: Article
ISSN: 0028-0836
DOI: 10.1038/317559b0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oncogene chromosome breakpoints and Alu

Oncogene chromosome breakpoints and Alu sequences

✍ ROGERS, JOHN 📂 Article 📅 1985 🏛 Nature Publishing Group 🌐 English ⚖ 129 KB

Sequence diversity and chromosomal distr

Sequence diversity and chromosomal distribution of “young” Alu repeats

✍ Santosh S. Arcot; Tamim H. Shaikh; Joomyeong Kim; Lesley Bennett; Michelle Alegr 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 552 KB

Analyzing functional genomic differences

Analyzing functional genomic differences yields oncogenes and chromosomal breakpoints in ALL and AML

✍ Butte, Atul J.; Reis, Ben; Kho, Alvin; Sun, Yao; Kohane, Isaac S. 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 28 KB

Regional chromosome localization of huma

Regional chromosome localization of human papillomavirus intergration sites near fragile sites, oncogenes, and cancer chromosome breakpoints

✍ Linda A. Cannizzaro; Matthias Dürst; Michael J. Mendez; Barbara K. Hecht; Freder 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 288 KB

Fragile sites, cancer chromosome breakpo

Fragile sites, cancer chromosome breakpoints, and oncogenes all cluster in light G bands

✍ Frederick Hecht 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 356 KB

PRAD1/lCyclin D1 proto-oncogene: Genomic

PRAD1/lCyclin D1 proto-oncogene: Genomic organization, 5′ dna sequence, and sequence of a tumor-specific rearrangement breakpoint

✍ Toru Motokura; Dr. Andrew Arnold 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 687 KB

## Abstract __PRAD1__ (previously D11S287) is a putative proto‐oncogene at 11q13, activated by overexpression through gene rearrangement or gene amplification in several types of human tumors including parathyroid adenomas, centrocytic lymphomas and other B‐cell tumors with t(11;14), and breast can